Dr. Leonard Saltz, MD

  • New York, NY
  • Medical oncologist
NPI1790756625PAC ID6800924184
Medicare services, 2024
733
Medicare patients, 2024
291
Part D claims, 2024
196
Publications
264
Clinical trials
1
Practice address
1275 York Avenue, New York, NY 10065
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Memorial Sloan Kettering Cancer Center

Hospital · New York, New York

See all 6 affiliations

Find Dr. Saltz's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Leonard Saltz is a medical oncologist in New York, New York

Dr. Saltz practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Saltz's NPI, 1790756625, was assigned on January 30, 2006. Dr. Saltz graduated from Yale School of Medicine in 1983. Dr. Saltz holds New York license 162425.

NPI and contact details
Medicare PAC ID
6800924184
NPI enumeration date
January 30, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
69
Medical school graduation
1983

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Leonard Saltz practices at Memorial Sloan Kettering Cancer Center in New York, New York

Dr. Saltz's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Source: Dmand AI Affiliation Data

Dr. Leonard Saltz is affiliated with 4 sites of care and 2 medical groups

Dr. Saltz's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Saltz to 2 more group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

See all 6 affiliations for Dr. Saltz

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Leonard Saltz's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saltz practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Memorial Sloan Kettering Cancer CenterAvailable with a free account
+3 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Saltz practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Leonard Saltz is one of 458 medical oncologists in New York

Medical oncology is Dr. Saltz's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Saltz is licensed in New York.

Specialties and state licenses

  • Medical oncology, New YorkPrimaryLicense 162425 · taxonomy 207RX0202X

Medical oncologists near Dr. Saltz

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Leonard Saltz billed Medicare for 733 services in 2024

CMS data shows 733 Medicare services from Dr. Saltz across 6 procedure codes in 2024, for 291 Medicare patients. Medicare paid $74,019 for them.

Medicare services, 2024733
Medicare patients291
Paid by Medicare$74,019
Procedure codes6

Dr. Saltz's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 6202024: 73318%

Where Dr. Saltz's Medicare services took place, 2024

  • In an office67993%
  • In a facility547%

Dr. Saltz compared with the New York median for medical oncologists, 2024

  • Dr. Saltz
  • New York median
Medicare services
733vs 3402.2 times
Medicare patients
291vs 1122.6 times
Part D claims
76vs 13042% below

Medians across 421 medical oncologists in New York with Dmand AI profiles that report each measure.

Dr. Saltz's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Saltz

Need commercial claims for Dr. Saltz?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Saltz and other medical oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Leonard Saltz treated 291 Medicare patients in 2024, average age 73

CMS counts 291 Medicare patients who saw Dr. Saltz in 2024. The largest group is 65 to 74, with 139 patients. 75% of them have cancer, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Saltz's median patient age at 69, with 51% women.

Medicare patients, 2024291
Average age73
Average risk score2.31
Also on Medicaid15%

Dr. Saltz's Medicare patients by age, 2024

Dr. Saltz's Medicare patients by sex, 2024

  • Women16256%
  • Men12944%

Chronic conditions among Dr. Saltz's Medicare patients, 2024

  1. Cancer75%
  2. High cholesterol75%
  3. High blood pressure67%
  4. Arthritis42%
  5. Ischemic heart disease30%
  6. Diabetes29%
  7. Anxiety26%
  8. Mood disorders24%

Share of Medicare patients with each condition. A patient can have several.

Dr. Saltz's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women51%
  • Men48%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Leonard Saltz wrote 196 Medicare Part D claims in 2024

In 2024, Dr. Saltz wrote 196 Medicare Part D claims for 76 patients. 84% of them were for generic drugs. CMS names the drug for 76 of them, across 3 drugs with 11 or more claims each, at $621 in total drug cost. In 2023, CMS named 55 claims across 3 drugs.

Part D claims, 2024196
Drugs named by CMS3
Total drug cost$621
Part D patients76

Dr. Saltz's Part D claims by kind of drug, 2024

  • Generic164 claims84%
  • Brand-name32 claims16%

Dr. Saltz's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Saltz's Part D claims, 2024

  • Opioids7%13 of 196 claims
  • Antibiotics6%12 of 196 claims
  • Antipsychotics, patients 65 and over15%29 of 196 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 552024: 7638%

Drugs named by CMS: 3 in 2024, 3 in 2023.

See all prescribing by Dr. Saltz

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Leonard Saltz scored 76 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Saltz for performance year 2024, reported as part of a group. Dr. Saltz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Saltz as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Saltz's MIPS scores, performance year 2024

  • 76of 100Final score
  • 60.6of 100Quality
  • 40of 100Improvement Activities
  • 74of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Saltz by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Leonard Saltz has 264 publications on record

Dmand AI links 264 papers to Dr. Saltz, published from 2004 to 2025. 2017 was the busiest year, with 17. The most frequent topics are Colorectal Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Colonic Neoplasms. Dr. Saltz has published most often in J Clin Oncol. Dr. Saltz's most frequent co-authors are Martin R. Weiser, MD, Philip B. Paty, MD and Zsofia K. Stadler, MD.

Papers264
Years published2004 to 2025

Dr. Saltz's papers by year, 2016 to 2025

Topics Dr. Saltz writes about most

  • Colorectal Neoplasms
  • Antineoplastic Combined Chemotherapy Protocols
  • Colonic Neoplasms
  • Rectal Neoplasms
  • Antineoplastic Agents
  • Fluorouracil
  • Chemotherapy, Adjuvant
  • Neoadjuvant Therapy

Dr. Saltz's most frequent co-authors

Recent publications by Dr. Saltz

See all 264 publications and co-authors

See who Dr. Saltz researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Saltz works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Leonard Saltz has worked on 1 clinical trial

Dmand AI links Dr. Saltz to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Rectal Neoplasms and Rectal Diseases.

Conditions in Dr. Saltz's trials

  • Rectal Neoplasms
  • Rectal Diseases

Investigators on the most trials with Dr. Saltz

Recent clinical trials with Dr. Saltz

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Leonard Saltz received $5,467 in industry payments in 2018

CMS Open Payments shows 3 general payments to Dr. Saltz from 1 drug or device company in 2018. Speaker and faculty fees make up the largest share, 100% of the total. Genentech, Inc. paid the most, $5,467.

Companies that paid Dr. Saltz the most, 2018 to 2018

Share is of all general payments to this clinician.

See all payments to Dr. Saltz

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Leonard Saltz graduated from Yale School of Medicine

Dr. Saltz graduated from Yale School of Medicine in 1983.

  1. Medical schoolYale School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Leonard Saltz's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Leonard Saltz

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Leonard Saltz's NPI number?

Dr. Leonard Saltz's NPI number is 1790756625. It was assigned on January 30, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Leonard Saltz?

Dr. Leonard Saltz is a medical oncologist in New York, New York. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Leonard Saltz practice?

Dr. Saltz practices at 1275 York Avenue, New York, NY 10065. Dr. Saltz's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Saltz to 2 group practices and clinics, 1 home health agency and 1 medical group.

What is Dr. Leonard Saltz's medical license number?

Dr. Saltz holds New York license 162425.

Which hospitals is Dr. Leonard Saltz affiliated with?

Dr. Saltz practices at Memorial Sloan Kettering Cancer Center in New York, New York.

What medical group is Dr. Leonard Saltz part of?

Dr. Saltz is linked to Memorial Sloan Kettering Cancer Center. Dmand AI links Dr. Saltz to 1 more medical group.

Does Dr. Leonard Saltz accept Medicare?

Yes. CMS data shows Dr. Saltz billed Medicare for 733 services in 2024, and Dr. Saltz accepts Medicare assignment.

Does Dr. Leonard Saltz offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Saltz as offering telehealth services.

What is Dr. Leonard Saltz's MIPS score?

Dr. Saltz's MIPS final score for performance year 2024 is 76 out of 100, reported as part of a group.

How many Medicare patients does Dr. Leonard Saltz see?

CMS counts 291 Medicare patients who saw Dr. Saltz in 2024, with an average age of 73.

Show 7 more questionsShow fewer questions

What services does Dr. Leonard Saltz bill to Medicare?

In 2024, Dr. Saltz's most billed Medicare services were office visit, established patient (99214), office visit, new patient (99205) and office visit, established patient (99213).

Where did Dr. Leonard Saltz go to medical school?

Dr. Saltz graduated from Yale School of Medicine in 1983.

What drugs does Dr. Leonard Saltz prescribe most?

In 2024 Medicare Part D data, Dr. Saltz's most prescribed drugs by claims were Pantoprazole Sodium, Olanzapine and Prednisone.

Has Dr. Leonard Saltz received payments from drug or device companies?

CMS Open Payments shows $5,467 in general payments to Dr. Saltz from 1 company from 2018 to 2018. The largest total came from Genentech, Inc.

How long has Dr. Leonard Saltz been practicing?

Dr. Saltz graduated from medical school in 1983, 43 years ago.

Does Dr. Leonard Saltz do research?

Dmand AI links 264 publications to Dr. Saltz, published from 2004 to 2025. Dr. Saltz has worked on 1 clinical trial.

Who does Dr. Leonard Saltz publish with?

Dr. Saltz's most frequent co-authors are Martin R. Weiser, MD (58 shared papers), Philip B. Paty, MD (39 shared papers) and Zsofia K. Stadler, MD (34 shared papers).

Selling to medical oncology practices?

See medical oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)